Jurkat cells treated with the ITK inhibitor showed a concentration-dependent reduced susceptibility for HIV-1 transductions that were mediated by the HIV envelope protein, but infections were not repressed when VSV-G pseudotypes were tested. The gene discussed is ITK; the disease is infection.